Target intelligence / Profile preview

Major Histocompatibility Complex Class I-Related Chain A (MICA), Major Histocompatibility Complex Class I-Related Chain B (MICB), and UL16-Binding Proteins (ULBP1-6) (NKG2D Ligands)

Target
NKG2D Ligands
Molecular classification
Receptor ligands, MHC class I homologs, Stress-induced self-antigens, Immune activating molecules
01

Overview

NKG2D ligands are a family of stress-induced cell surface molecules, structurally related to MHC class I, that are upregulated on cells undergoing transformation, infection, or other stress. In humans, the main members are MICA, MICB, and UL16-binding proteins (ULBP1–6). These ligands are recognized by the activating immune receptor NKG2D, found on γδ T cells, NK cells, and CD8^+^ T cells. Their engagement triggers cytotoxicity and cytokine release, contributing to antitumor immunity. Tumors frequently adapt by shedding these ligands or downregulating their expression to evade immune attack, yet pharmacological enhancement of their surface expression is a promising immunotherapeutic strategy.

Other names
NKG2D ligandsStress-induced ligandsMICA/MICBUL16-binding proteins (ULBP1–6)Rae-1, Mult1, H60 (mouse homologs)
02

Mechanism of action

Upregulation of ligand expression to improve immune recognition Epigenetic modulation to maintain ligand surface expression Inhibition of ligand shedding to prevent immune evasion Stimulation of cytotoxicity via NKG2D receptor signaling

03

Biological functions

Immune surveillanceActivation of cytotoxic lymphocytesSignal transductionModulation of cell death/apoptosisImmune regulation
04

Disease associations

Cancer (tumor recognition, evasion)Infection (virus, bacterial)Autoimmunity (overactivation)Inflammatory diseases
05

Safety considerations

Off-target tissue damage due to extensive NKG2D ligand expressionImmune escape due to ligand downregulation or sheddingRisk of autoimmunity/inflammation from unchecked activation
06

Interacting drugs

Valproic acid (modulates NKG2D ligand/receptor expression via epigenetic mechanisms)

1 more in the full profile.

07

Biomarkers

Surface expression of MICA/B, ULBP1–6 on tumor cellsLevels of soluble NKG2D ligands in serum (shedding often correlates with worse prognosis)Frequency of NKG2D+ γδ T cells as predictor in pregnancy outcomes

Beyond the preview

Go deeper on Major Histocompatibility Complex Class I-Related Chain A (MICA), Major Histocompatibility Complex Class I-Related Chain B (MICB), and UL16-Binding Proteins (ULBP1-6) (NKG2D Ligands).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major Histocompatibility Complex Class I-Related Chain A (MICA), Major Histocompatibility Complex Class I-Related Chain B (MICB), and UL16-Binding Proteins (ULBP1-6) (NKG2D Ligands).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call